Jarkko Hytönen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jarkko Hytönen has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Jouni Taavitsainen
Heart Center, Kuopio University Hospital, 70210 Kuopio, Finland
1 shared publication - Juha Hartikainen
University of Eastern Finland
1 shared publication - Ville Vepsäläinen
Heart Centre, Kuopio University Hospital, Kuopio, Finland
1 shared publication
Latest Publications
- Open Access
- 13 March 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (3) , 139
Heart Failure and a Large Ventricular Thrombus Following COVID-19 Infection
Severe cases of heart failure (HF), both new onsets of HF and acute exacerbations of chronic HF, are frequently observed during infections. A potentially lethal complication of HF with very low left ventricular ejection fraction is thrombus formation within the heart chambers. A 67-year-old male was admitted to our hospital with shortness of breath after a COVID-19 infection. He was diagnosed with severe acute heart failure and a massive thrombus in the left ventricle. While the thrombus subsided quickly without any observable embolic events, the patient had a lengthy hospitalization stay complicated by tachyarrhythmias and secondary infections. Eventually, his heart failure improved, and he continued to recover post-hospital discharge. We present a case of severe heart failure and intraventricular thrombosis following COVID-19 infection. The patient required potent anti-inflammatory medication in addition to conventional heart failure medication to recover from his HF.
- 13 March 2026
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 13 (3) , 139
Open AccessHeart Failure and a Large Ventricular Thrombus Following COVID-19 Infection
Severe cases of heart failure (HF), both new onsets of HF and acute exacerbations of chronic HF, are frequently observed during infections. A potentially lethal complication of HF with very low left ventricular ejection fraction is thrombus formation within the heart chambers. A 67-year-old male was admitted to our hospital with shortness of breath after a COVID-19 infection. He was diagnosed with severe acute heart failure and a massive thrombus in the left ventricle. While the thrombus subsided quickly without any observable embolic events, the patient had a lengthy hospitalization stay complicated by tachyarrhythmias and secondary infections. Eventually, his heart failure improved, and he continued to recover post-hospital discharge. We present a case of severe heart failure and intraventricular thrombosis following COVID-19 infection. The patient required potent anti-inflammatory medication in addition to conventional heart failure medication to recover from his HF.